MaxCyte
MXCT
119 hedge funds and large institutions have $303M invested in MaxCyte in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 21 closing their positions.
211% more call options, than puts
Call options by funds: $84K | Put options by funds: $27K
50% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 30
13% more capital invested
Capital invested by funds: $268M → $303M (+$34.5M)
3.43% more ownership
Funds ownership: 65.4% → 68.83% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 21
1% less funds holding
Funds holding: 120 → 119 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
+$14M |
| 2 |
RGI
River Global Investors
London,
United Kingdom
|
+$4.5M |
| 3 |
CCM
Cadian Capital Management
New York
|
+$4.37M |
| 4 |
Axa
Paris,
France
|
+$3.73M |
| 5 |
RA
Royce & Associates
New York
|
+$1.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.49M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.34M |
| 3 |
BlackRock
New York
|
-$1.76M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
-$1.66M |
| 5 |
Morgan Stanley
New York
|
-$1.55M |
MXCT Hedge Fund Activity: Q4 2024 in Review
119 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q4 2024, worth a combined $303M — up 13% from $268M a quarter earlier.
Fund positioning in MXCT was balanced in Q4 2024: 21 funds opened new positions, 21 closed out, 45 added to existing stakes and 30 trimmed.
The largest buyer was Mirabella Financial Services, opening a new position worth an estimated $14M. The largest seller was Millennium Management, cutting an estimated $5.49M.
- 119 institutional investors held MaxCyte (MXCT) as of Q4 2024, down from 120 in Q3 2024.
- Funds reported $303M of MaxCyte stock for Q4 2024, up 13% quarter-over-quarter.
- 21 funds opened new MaxCyte positions in Q4 2024 and 21 closed out, a net change of 0 holders.
- The largest MaxCyte buyer in Q4 2024 was Mirabella Financial Services, an estimated $14M added.
- The largest MaxCyte seller in Q4 2024 was Millennium Management, an estimated $5.49M sold.
Based on aggregated 13F filings for Q4 2024.